within Pharmacolibrary.Drugs.ATC.N;

model N02AX05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 1120 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.0026,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0028333333333333335,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Meptazinol is an opioid analgesic used for the relief of moderate to severe pain. It acts as a partial agonist at opioid receptors, primarily the μ-opioid receptor. It was previously used especially in obstetric analgesia (e.g., labor pain), but its use has largely declined and is not common in current clinical practice due to the availability of safer or more effective alternatives.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult volunteers (mixed sex) following single oral administration.</p><h4>References</h4><ol><li><p>Norbury, HM, et al., &amp; Sinha, B (1984). Pharmacokinetics of meptazinol after single and multiple oral administration to elderly patients. <i>European journal of clinical pharmacology</i> 27(2) 223–226. DOI:<a href=&quot;https://doi.org/10.1007/BF00544049&quot;>10.1007/BF00544049</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6499901/&quot;>https://pubmed.ncbi.nlm.nih.gov/6499901</a></p></li><li><p>Norbury, HM, et al., &amp; Graham, DF (1983). Pharmacokinetics of the new analgesic, meptazinol, after oral and intravenous administration to volunteers. <i>European journal of clinical pharmacology</i> 25(1) 77–80. DOI:<a href=&quot;https://doi.org/10.1007/BF00544019&quot;>10.1007/BF00544019</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6617729/&quot;>https://pubmed.ncbi.nlm.nih.gov/6617729</a></p></li><li><p>Franklin, RA (1988). The clinical pharmacokinetics and metabolism of the analgesic meptazinol. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 18(1) 105–112. DOI:<a href=&quot;https://doi.org/10.3109/00498258809055141&quot;>10.3109/00498258809055141</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3354226/&quot;>https://pubmed.ncbi.nlm.nih.gov/3354226</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N02AX05;
